Literature DB >> 1900269

High-level expression of human c-jun gene causes cellular transformation of chicken embryo fibroblasts.

T Suzuki1, Y Hashimoto, H Okuno, H Sato, H Nishina, H Iba.   

Abstract

To analyze the transforming activity of c-jun, a Rous sarcoma virus (RSV) variant that carries human c-jun instead of v-src (JH1) was constructed. After infection onto chicken embryo fibroblasts (CEF), JH1 formed foci with a titer comparable to that of wild-type RSV, and the infected cells grew in soft agar, indicating that the human c-jun gene has transforming potential, like the v-jun gene. The expression of Fra-2, one of the recently isolated Fos-related antigens, but not Fos was detected in both JH1-infected CEF and CEF infected with the control retrovirus vector (DS3). Gel shift analysis using nuclear extracts from DS3-infected CEF revealed that the Fra-2/Jun complex contributes to the basal level of AP-1 DNA binding activity. A similar activity was detected in JH1-infected CEF, but these cells have an additional AP-1 binding activity derived from Jun homodimers that seems to play important roles in the cellular transformation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900269      PMCID: PMC5918208          DOI: 10.1111/j.1349-7006.1991.tb01746.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  28 in total

1.  The avian cellular homolog of the oncogene jun.

Authors:  T Nishimura; P K Vogt
Journal:  Oncogene       Date:  1988-12       Impact factor: 9.867

2.  Identification of a small region of the v-fos gene product that is sufficient for transforming potential and growth-stimulating activity.

Authors:  T Yoshida; Y Shindo; K Ohta; H Iba
Journal:  Oncogene Res       Date:  1989

3.  Fos and Jun bind cooperatively to the AP-1 site: reconstitution in vitro.

Authors:  F J Rauscher; P J Voulalas; B R Franza; T Curran
Journal:  Genes Dev       Date:  1988-12       Impact factor: 11.361

4.  Rapid transformation of cells by Rous sarcoma virus.

Authors:  H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1969-06       Impact factor: 11.205

5.  Avian sarcoma virus 17 carries the jun oncogene.

Authors:  Y Maki; T J Bos; C Davis; M Starbuck; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  Transformation of chicken embryo fibroblasts and tumor induction by the middle T antigen of polyomavirus carried in an avian retroviral vector.

Authors:  S Kornbluth; F R Cross; M Harbison; H Hanafusa
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

7.  Rous sarcoma virus variants that carry the cellular src gene instead of the viral src gene cannot transform chicken embryo fibroblasts.

Authors:  H Iba; T Takeya; F R Cross; T Hanafusa; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

8.  Nucleoprotein complexes that regulate gene expression in adipocyte differentiation: direct participation of c-fos.

Authors:  R J Distel; H S Ro; B S Rosen; D L Groves; B M Spiegelman
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

9.  Induction of protooncogene c-jun by serum growth factors.

Authors:  K Ryder; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

10.  c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities.

Authors:  T D Halazonetis; K Georgopoulos; M E Greenberg; P Leder
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

View more
  12 in total

1.  Human leucine zipper protein sLZIP induces migration and invasion of cervical cancer cells via expression of matrix metalloproteinase-9.

Authors:  Hyereen Kang; Sung-Wuk Jang; Jesang Ko
Journal:  J Biol Chem       Date:  2011-10-18       Impact factor: 5.157

2.  Novel DNA binding specificities of a putative herpesvirus bZIP oncoprotein.

Authors:  Z Qian; P Brunovskis; L Lee; P K Vogt; H J Kung
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

3.  Chondrocytes as a specific target of ectopic Fos expression in early development.

Authors:  H Watanabe; K Saitoh; T Kameda; M Murakami; Y Niikura; S Okazaki; Y Morishita; S Mori; Y Yokouchi; A Kuroiwa; H Iba
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

4.  Specific activation in jun-transformed avian fibroblasts of a gene (bkj) related to the avian beta-keratin gene family.

Authors:  M Hartl; K Bister
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

5.  Immortalization-susceptible elements and their binding factors mediate rejuvenation of regulation of the type I collagenase gene in simian virus 40 large T antigen-transformed immortal human fibroblasts.

Authors:  S Imai; T Fujino; S Nishibayashi; T Manabe; T Takano
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

Review 6.  Role of BMK1 in regulation of growth factor-induced cellular responses.

Authors:  Y Kato; T H Chao; M Hayashi; R I Tapping; J D Lee
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

7.  Analysis of AP-1 function in cellular transformation pathways.

Authors:  T Suzuki; M Murakami; N Onai; E Fukuda; Y Hashimoto; M H Sonobe; T Kameda; M Ichinose; K Miki; H Iba
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  Overexpression of c-jun, junB, or junD affects cell growth differently.

Authors:  M Castellazzi; G Spyrou; N La Vista; J P Dangy; F Piu; M Yaniv; G Brun
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

9.  Difference in transcriptional regulatory function between c-Fos and Fra-2.

Authors:  T Suzuki; H Okuno; T Yoshida; T Endo; H Nishina; H Iba
Journal:  Nucleic Acids Res       Date:  1991-10-25       Impact factor: 16.971

10.  JunD mutants with spontaneously acquired transforming potential have enhanced transactivating activity in combination with Fra-2.

Authors:  T Kameda; A Akahori; M H Sonobe; T Suzuki; T Endo; H Iba
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.